Loading publications…
The last 5 uploaded publications
Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy
Mees Egeler, Julia Lai‐Kwon, Renaud Tissier, Itske Fraterman, Anke Kuijpers, Winan J. van Houdt, Sofie Wilgenhof, Aparna D. Rao, Shahneen Sandhu, Rebecca Lee, Hanna Eriksson, Marieke van Leeuwen, Kelly de Ligt, Alexander C.J. van Akkooi, Lonneke V. van de Poll‐Franse (2024). Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy. , 200, DOI: https://doi.org/10.1016/j.ejca.2024.113601.
Article63 days agoAdjuvant therapy for stage II melanoma: the need for further studies
Rebecca Lee, Mario Mandalà, Georgina V. Long, Alexander M.M. Eggermont, Alexander C.J. van Akkooi, Shahneen Sandhu, Claus Garbe, Paul Lorigan (2023). Adjuvant therapy for stage II melanoma: the need for further studies. , 189, DOI: https://doi.org/10.1016/j.ejca.2023.05.003.
Article63 days agoP56 Trial redesign for the phase II/III DETECTION trial: circulating tumour DNA-guided therapy for stage IIB/C melanoma after surgical resection
Andy Muinonen-Martin, Rebecca Lee, Dominic G. Rothwell, Richard A. Jackson, Nigel Smith, Stephen Q. Wong, Noel Kelso, Chelsee Hewitt, Jackie Mitchell, Kate Jones, Samra Turajlic, Pippa Corrie, Richard Marais, Mark R. Middleton, Sarah‐Jane Dawson, Shahneen Sandhu, Caroline Dive, Paul Lorrigan (2023). P56 Trial redesign for the phase II/III DETECTION trial: circulating tumour DNA-guided therapy for stage IIB/C melanoma after surgical resection. , 188(Supplement_4), DOI: https://doi.org/10.1093/bjd/ljad113.084.
Article63 days agoDETECTION phase II/III trial: Circulating tumor DNA–guided therapy for stage IIB/C melanoma after surgical resection.
Rebecca Lee, Dominic G. Rothwell, Richard A. Jackson, Nigel Smith, Stephen Q. Wong, Noel Kelso, George J. Burghel, Chelsee Hewitt, Harry S. Clarke, Jackie Mitchell, Kate Jones, Andrew Muinonen‐Martin, Samra Turajlic, Pippa Corrie, Richard Marais, Mark R. Middleton, Sarah‐Jane Dawson, Shahneen Sandhu, Caroline Dive, Paul Lorigan (2022). DETECTION phase II/III trial: Circulating tumor DNA–guided therapy for stage IIB/C melanoma after surgical resection.. , 40(16_suppl), DOI: https://doi.org/10.1200/jco.2022.40.16_suppl.tps9603.
Article63 days agoPrediction and monitoring of relapse in stage III melanoma using circulating tumor DNA
Lavinia Tan, Shahneen Sandhu, Rebecca Lee, James Li, Jason Callahan, Sarah Ftouni, Nathalie Dhomen, Philippa Middlehurst, Andrea Wallace, Jeanette Raleigh, Athena Hatzimihalis, Michael A. Henderson, Mark Shackleton, Andrew Haydon, Victoria Mar, David Gyorki, D. Oudit, Mark A. Dawson, Rodney J. Hicks, Paul Lorigan, Grant A. McArthur, Richard Marais, Stephen Q. Wong, Sarah‐Jane Dawson (2019). Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA. , 30(5), DOI: https://doi.org/10.1093/annonc/mdz048.
Article63 days ago